Paradigm Capital Management Inc. NY Purchases 17,900 Shares of Integer Holdings Corporation $ITGR

Key Points

• Paradigm Capital Management Inc. NY significantly increased its holdings in Integer Holdings Corporation by 426.2% during Q1, bringing its ownership to approximately 0.06% valued at over $2.6 million.
• A range of institutional investors are active in Integer's stock, with hedge funds owning 99.29% of the company's shares, indicating a strong interest in this medical equipment provider.
• Integer's latest earnings report revealed a decline in EPS to $1.55 compared to the consensus estimate of $1.57, despite revenue growth of 11.4% year-over-year.

Paradigm Capital Management Inc. NY grew its holdings in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 426.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 22,100 shares of the medical equipment provider's stock after purchasing an additional 17,900 shares during the quarter. Paradigm Capital Management Inc. NY owned about 0.06% of Integer worth $2,608,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Opal Wealth Advisors LLC acquired a new position in Integer in the first quarter worth $28,000. AdvisorNet Financial Inc acquired a new position in Integer in the first quarter worth $28,000. SVB Wealth LLC acquired a new position in Integer in the first quarter worth $35,000. Bessemer Group Inc. boosted its stake in Integer by 73.1% in the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after purchasing an additional 125 shares in the last quarter. Finally, Headlands Technologies LLC boosted its stake in Integer by 1,234.8% in the first quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider's stock worth $145,000 after purchasing an additional 1,136 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Truist Financial reduced their price objective on Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a research note on Friday, July 25th. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and boosted their target price for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Raymond James Financial dropped their target price on Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a research report on Friday, July 25th. Wells Fargo & Company dropped their target price on Integer from $152.00 to $132.00 and set an "overweight" rating for the company in a research report on Friday, July 25th. Finally, Wall Street Zen upgraded Integer from a "hold" rating to a "buy" rating in a research report on Saturday, August 30th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Integer has an average rating of "Buy" and an average target price of $140.25.

Integer Trading Up 0.2%

NYSE:ITGR traded up $0.26 during mid-day trading on Friday, hitting $106.86. The company had a trading volume of 171,911 shares, compared to its average volume of 466,166. Integer Holdings Corporation has a fifty-two week low of $104.93 and a fifty-two week high of $146.36. The business's fifty day moving average is $111.61 and its two-hundred day moving average is $117.19. The firm has a market cap of $3.74 billion, a P/E ratio of 46.98, a P/E/G ratio of 0.83 and a beta of 1.03. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.18 and a current ratio of 3.41.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a return on equity of 12.27% and a net margin of 4.61%.The business had revenue of $476.00 million during the quarter, compared to the consensus estimate of $464.37 million. During the same quarter last year, the company earned $1.30 earnings per share. The firm's revenue was up 11.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, research analysts expect that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.